ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance
2026-02-27
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
2026-02-24
$76.75
+0.65 ( 0.85% )
Pricing delayed by 20 minutes
Last updated
2026-03-04 15:43:00